UCLPartners

UCLPartners is an academic health science partnership with over 40 higher education and NHS members in parts of London, Hertfordshire, Bedfordshire and Essex. Together, its member organisations from higher education and the NHS form one of the world’s leading centres of medical discovery, healthcare innovation and education.

Great Ormond Street Hospital (GOSH) is a founding member of UCLPartners and through UCLPartners, we are working together to improve health outcomes and create wealth for the local population at scale and pace.

UCLPartners is unique because it facilitates the improvement of healthcare through a range of clinical and academic designated roles. It is an Academic Health Science Centre (AHSC), Academic Health Science Network (AHSN) and an Education Lead Provider. It is also aligned with the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) and the NIHR Clinical Research Network (CRN) North Thames. It is the only academic health science partnership in the country to align these NHS and Department of Health designated roles under one umbrella. By aligning these functions UCLPartners is able to achieve the best opportunity to translate innovation into health and wealth benefits for patients.

100,000 health professionals and academics from distinguished hospital and university member organisations are brought together to work in partnership and further collaborate with patient groups, commissioners, primary care, community care, the third sector, government and industry on a portfolio of health programmes. These programmes address the needs of the local population and are aligned to the requirements of its designated roles. Beyond serving the population of six million people, the healthcare solutions developed by members can be applied across the UK and globally.

UCLPartners supports the North Thames Genomic Medicine Centre (NTGMC) which brings together six hospital trusts in north London, including GOSH. The NTGMC has been set up to help gain a better understanding of the genetic causes of cancer, rare disorders and infectious diseases and is  contributing to the Government’s 100,000 Genomes Project.